StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Raised to $300 at Oppenheimer
May 14, 2026 12:04 PM
(Updated - May 14, 2026 12:04 PM EDT)
Oppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change